Dr. Lea Moukarzel of Gynecologic Oncology at Jefferson Abington Hospital joins us to answer all of your questions about the use of antibody–drug conjugates (ADCs) as a treatment for ovarian cancer.
Gynecologic Oncology ; Antibody-Drug Conjugates ; ADCs ; Ovarian Cancer Treatment ; ADCs in ovarian cancer ; Antibody-based cancer therapies ; Targeted cancer therapies for ovarian cancer ; Gynecologic oncologist Q&A ; ADC effectiveness in cancer ; Ovarian cancer treatment advancements
